Initial nonadherence, primary failure and therapeutic success of metformin monotherapy in clinical practice

Current Medical Research and Opinion

Volumn 26, Issue 9, 2010, Pages 2127-2135

  Nichols, Gregory A ^a   Conner, Christopher ^b   Brown, Jonathan B ^a  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

Diabetes; Glycemic control; Metformin; Nonadherence; Therapy failure

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; DIABETIC PATIENT; DRUG TREATMENT FAILURE; FEMALE; GLYCEMIC CONTROL; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT REFUSAL;

ADULT; AGED; ALGORITHMS; COHORT STUDIES; DATABASES AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; METFORMIN; MIDDLE AGED; OREGON; PATIENT COMPLIANCE; PROFESSIONAL PRACTICE; TREATMENT FAILURE; TREATMENT OUTCOME; WASHINGTON;

EID: 77955605193     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2010.504396     Document Type: Article

References (23)

1. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2006;29:1963-1972
2. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2009;32:193-203
3. Nichols GA, Alexander CM, Girman CJ, et al. Treatment escalation and rise in HbA1c following successful initial metformin therapy. Diabetes Care 2006; 29:504-509
4. Nichols GA, Alexander CM, Girman CJ, et al. Contemporary analysis of secondary failure of successful sulfonylurea therapy. Endocr Pract 2007; 13:37-44
5. DeFronzo RA, Goodman AM, and the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:541-549
6. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-579
7. Inzuchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002; 287:360-372
8. Nichols GA, Gomez-Caminero A. Weight changes following the initiation of new anti-hyperglycemic therapies. Diabetes Obes Metabol 2007; 9:96-102
9. UKPDS Group. UKPDS 34: Effect of intensive blood-glucose control with metformin on complications on overweight patients with type 2 diabetes. Lancet 1998;352:854-865
10. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427-2443
11. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care 2004;27:1535-1540
12. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997; 50:105-116
13. Lawrence DB, Ragucci KR, Long LB, et al. Relationship of oral antihyperglycemic (sulfonylurea or metformin) medication adherence and hemoglobin A1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006;12:466-471
14. Battista RN. Implementing Preventive Services. New York, NY: American Journal of Preventive Medicine, 1988
15. Karter AJ, Moffet HH, Liu J, et al. Glycemic response to newly initiated diabetes therapies. Am J Manag Care 2007;13:598-606
16. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycemic therapy: evaluation of a population of type 2 diabetes patients. J Int Med Res 2002;30:71-79
17. DeFronzo RA. From the triumvariate to the ominus octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009;58:773-795
18. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on type 2 Diabetes Mellitus: an algorithm for glycemic control. Endocr Pract 2009;15:540-559
19. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
20. Feldstein AC, Nichols GA, Smith DH, et al. Weight change in diabetes and glycemic and blood pressure control. Diabetes Care 2008;31:1960-1965
21. Rhee MK, Slocum W, Ziemer DC, et al. Patient adherence improves glycemic control. Diabetes Educ 2005;31:240-250
22. Krapek K, King K, Warren SS, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004;38:1357-1362
23. Boccuzzi SJ, Wogen J, Fox J, et al. Utilization of oral antihyperglycemic agents in a drug-insured US population. Diabetes Care 2001;24:1411-1415